Trials / Unknown
UnknownNCT01411761
Effect of Saccharomyces Boulardii on Indirect Hyperbilirubinemia and Phototherapy Duration in Very Low Birth Weight Infants
Phase 4 Study of Saccharomyces Boulardii on Indirect Hyperbilirubinemia
- Status
- Unknown
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 80 (estimated)
- Sponsor
- Zekai Tahir Burak Women's Health Research and Education Hospital · Academic / Other
- Sex
- All
- Age
- 1 Day – 15 Days
- Healthy volunteers
- Not accepted
Summary
Indirect hyperbilirubinemia is frequently observed in premature infants.Probiotics are favorable microorganisms that regulate the flora of the gastrointestinal system. In this study we aimed to compare the effect of S. boulardii on severity of hyperbilirubinemia and duration of phototherapy on very low birth weight infants.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DIETARY_SUPPLEMENT | Reflor | 5 million unit/day, first 15 day of life |
| OTHER | serum physiologic | 1 cc added to one feeding in a day |
Timeline
- Start date
- 2011-05-01
- Primary completion
- 2011-12-01
- Completion
- 2011-12-01
- First posted
- 2011-08-08
- Last updated
- 2011-08-08
Locations
1 site across 1 country: Turkey (Türkiye)
Source: ClinicalTrials.gov record NCT01411761. Inclusion in this directory is not an endorsement.